Bing

SEARCH HISTORY

Clovis Oncology (NASDAQ:CLVS)‘s stock had its “buy” rating reiterated by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Monday. Clovis Oncology (NASDAQ:CLVS) traded down 5.88% on Monday …
Ticker Report · 3 hours ago
OM Group (NYSE: OMG) 27.9% HIGHER; announced that it has entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO) (together with its …
StreetInsider · 12 hours ago
Pdl Biopharma (PDLI): PDLI stock is up 1.0% today. Some of the biggest losers among healthcare stocks include: Clovis Oncology Inc (CLVS): CLVS stock is down 2.8% today. Mannkind Corp (MNKD): MNKD stock is down 2.8% today. Sarepta …
Investor Place · 5/28/2015
More from Bing News
Clovis fell 5% to 87.63 in Monday market action. Peter Lawson at Mizuho Securities recommended buying the stock on today’s weakness. As he wrote: We would be buyers of CLVS on any weakness and are raising our PT from $100 to $103 on the …
Barron's · ByJohanna Bennett · 7 hours ago
Clovis Falls
Agrees to Buy Sheplers for $147m Cash Biotech/Pharma Stocks Gain: * IMGN +50.6%; Ovarian Cancer Drug Has 53% Response Rate in Study * RXDX +24.6%; Phase 1 Trial Data for Entrectinib * ONTY +19.6%; ONT-380 Data Backs Plans to Initiate …
Bloomberg · 11 hours ago
Related Link: Airline Stocks Rally On Southwest Airlines' CEO Comments Shares ... Inversely, Clovis Oncology Inc (NASDAQ: CLVS) is among the biggest losers of the day, after the company presented data that a …
Yahoo Finance · 5 hours ago
ASCO Conference
CHICAGO (The Street) -- It seems impossible to invest in, think about (or write on) Clovis Oncology (CLVS) without first considering the ... Must Read: Warren Buffet's Top 10 Stock Buys But AstraZeneca fought back Sunday when a highly anticipated ...
The Street · ByAdam Feuerstein · 16 hours ago
Zeltiq Aesthetics Inc (ZLTQ)- The company’s stocks lost 1.3 pct. Clovis Oncology Inc (CLVS)- The company’s shares shed 1.2 pct. Lannett Co Inc (LCI)- The company’s stocks retreated 1.2 pct.
Fx Pips · 5/22/2015
Over the last 30 days, the company witnessed four negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher …
ZACKS · 5/15/2015
Clovis Oncology (NASDAQ:CLVS)‘s stock had its “buy” rating reiterated by Stifel Nicolaus in a research note issued on Saturday. They currently have a $125.00 price target on the stock, up from their previous price target of $90.00. Stifel Nicolaus ...
sleekmoney.com · 5/16/2015
Related Searches